Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages

This publication has 30 references indexed in Scilit:

• Alpha₁-Antitrypsin Deficiency — A Model for Conformational Diseases
  New England Journal of Medicine, 2002
• The Direct Medical Costs of α1-Antitrypsin Deficiency
  Chest, 2001
• Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease Inhibitor
  Chest, 2001
• α1-Antitrypsin Deficiency: Biological Answers to Clinical Questions
  The Lancet Healthy Longevity, 2001
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα₁-Antitrypsin with Negligible Toxicity
  Human Gene Therapy, 1998
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
  Nature Genetics, 1998
• Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration
  Nature Genetics, 1995
• Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes
  Hepatology, 1995
• Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.
  American Journal of Respiratory Cell and Molecular Biology, 1994
• Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo
  Science, 1991